ResearchMoz

The Insurance Industry in the Isle of Man, Key Trends and Opportunities to 2017

Timetric
Published Date » 2013-03-22
No. Of Pages » 92
 Synopsis 
    The report provides in depth market analysis, information and insights into the insurance industry in the Isle of Man, including: 
 
 The Manx insurance industrys growth prospects by insurance segments and categories  
 The competitive landscape in the Manx insurance industry 
 The current trends and drivers of the Isle of Man insurance industry 
 The challenges facing the Isle of Man insurance industry 
 The regulatory framework of the Isle of Man insurance industry 
 
 Summary    
 The Isle of Man is one of the leading offshore financial centers in the world. Business-friendly and transparent regulations coupled with excellent infrastructure have created a thriving business environment on the island. It successfully avoided the effects of the global...
Table of Content

1 Executive Summary

2 Introduction
2.1 What is this Report About?
2.2 Definitions
2.3 Methodology

3 Manx Industry Overview
3.1 Manx Insurance Industry
3.2 Key Industry Trends and Drivers
3.3 Challenges
3.4 Regulation

4 Industry Segmentation
4.1 Life Insurance
4.2 Non-Life Insurance
4.2.1 Property insurance
4.2.2 Motor insurance
4.2.3 Liability insurance
4.2.4 Marine, aviation and transit insurance
4.3 Personal Accident and Health Insurance

5 Competitive Landscape
5.1 Overview
5.2 Leading Companies
5.2.1 Tower Insurance - company overview
5.2.2 Isle of Man Assurance Group (IOMA) - company overview
5.2.3 Zurich International Life Ltd - company overview

6 Macroeconomic Indicators
6.1 GDP at Current Prices (US Dollars)
6.2 GDP per Capita (US dollar)
6.3 Inflation Rate
6.4 Employed Population
6.5 Healthcare Expenditure per Capita
6.6 Healthcare Expenditure as Percentage of GDP
6.7 Total Number of Air Passenger
6.8 Total Population

7 Appendix
7.1 Methodology
7.2 Contact Us
7.3 About Timetric
7.4 Disclaimer

List of Tables


Table 1: Insurance Industry Definitions
Table 2: Manx Insurance Industry - Overall Written Premium by Segment (GBP Billion),
Table 3: Manx Insurance Industry - Overall Written Premium by Segment (US$ Billion),
Table 4: Manx Insurance Industry - Overall Written Premium by Segment (GBP Billion),
Table 5: Manx Insurance Industry - Overall Written Premium by Segment (US$ Billion),
Table 6: Manx Insurance Industry - Segmentation (% Share), 2008-2017
Table 7: Manx Life Insurance - Gross Written Premium (GBP Billion), 2008-2012
Table 8: Manx Life Insurance - Paid Claims (GBP Billion), 2012-2017
Table 9: Manx Life Insurance - Paid Claims (GBP Billion), 2008-2012
Table 10: Manx Life Insurance - Paid Claims (GBP Billion), 2012-2017
Table 11: Manx Life Insurance - Incurred Loss (GBP Billion), 2008-2012
Table 12: Manx Life Insurance - Incurred Loss (GBP Billion), 2012-2017
Table 13: Manx Life Insurance - Loss Ratio (%), 2008-2012
Table 14: Manx Life Insurance - Loss Ratio (%), 2012-2017
Table 15: Manx Life Insurance - Combined Ratio (%), 2008-2012
Table 16: Manx Life Insurance - Combined Ratio (%), 2012-2017
Table 17: Manx Life Insurance - Total Assets (GBP Billion), 2008-2012
Table 18: Manx Life Insurance - Total Assets (GBP Billion), 2012-2017
Table 19: Manx Life Insurance - Total Investment Income (GBP Billion), 2008-2012
Table 20: Manx Life Insurance - Total Investment Income (GBP Billion), 2012-2017
Table 21: Manx Life Insurance - Retentions (GBP Billion), 2008-2012
Table 22: Manx Life Insurance - Retentions (GBP Billion), 2012-2017
Table 23: Manx Non-Life Insurance Written Premium by Category (GBP Billion), 2008-2012
Table 24: Manx Non-Life Insurance Written Premium by Category (US$ Billion), 2008-2012
Table 25: Manx Non-Life Insurance Written Premium by Category (GBP Billion), 2012-2017
Table 26: Manx Non-Life Insurance Written Premium by Category (US$ Billion), 2012-2017
Table 27: Manx Non-Life Insurance - Paid Claims (GBP Billion), 2008-2012
Table 28: Manx Non-Life Insurance - Paid Claims (GBP Billion), 2012-2017
Table 29: Manx Non-Life Insurance - Incurred Loss (GBP Billion), 2008-2012
Table 30: Manx Non-Life Insurance - Incurred Loss (GBP Billion), 2012-2017
Table 31: Manx Non-Life Insurance - Loss Ratio (%), 2008-2012
Table 32: Manx Non-Life Insurance - Loss Ratio (%), 2012-2017
Table 33: Manx Non-Life Insurance - Combined Ratio (%), 2008-2012
Table 34: Manx Non-Life Insurance - Combined Ratio (%), 2012-2017
Table 35: Manx Non-Life Insurance - Total Assets (GBP Billion), 2008-2012
Table 36: Manx Non-Life Insurance - Total Assets (GBP Billion), 2012-2017
Table 37: Manx Non-Life Insurance - Retentions (GBP Billion), 2008-2012
Table 38: Manx Non-Life Insurance - Retentions (GBP Billion), 2012-2017
Table 39: Manx Property Insurance - Written Premium (GBP Billion), 2008-2012
Table 40: Manx Property Insurance - Written Premium (GBP Billion), 2012-2017
Table 41: Manx Motor Insurance - Written Premium (GBP Billion), 2008-2012
Table 42: Manx Motor Insurance - Written Premium (GBP Billion), 2012-2017
Table 43: Manx Liability Insurance - Written Premium (GBP Billion), 2008-2012
Table 44: Manx Liability Insurance - Written Premium (GBP Billion), 2012-2017
Table 45: Manx Marine, Aviation and Transit Insurance - Written Premium (GBP Billion), 2008-2012
Table 46: Manx Marine, Aviation and Transit Insurance - Written Premium (GBP Billion), 2012-2017
Table 47: Manx Personal Accident and Health Insurance - Written Premium (GBP Billion), 2008-2012
Table 48: Manx Personal Accident and Health Insurance - Written Premium (GBP Billion), 2012-2017
Table 49: Manx Personal Accident and Health Insurance - Paid Claim (GBP Billion), 2008-2012
Table 50: Manx Personal Accident and Health Insurance - Paid Claim (GBP Billion), 2012-2017
Table 51: Manx Personal Accident and Health Insurance - Incurred Loss (GBP Billion), 2008-2012
Table 52: Manx Personal Accident and Health Insurance - Incurred Loss (GBP Billion), 2012-2017
Table 53: Manx Personal Accident and Health Insurance - Loss Ratio (%), 2008-2012
Table 54: Manx Personal Accident and Health Insurance - Loss Ratio (%), 2012-2017
Table 55: Manx Personal Accident and Health Insurance - Combined Ratio (%), 2008-2012
Table 56: Manx Personal Accident and Health Insurance - Combined Ratio (%), 2012-2017
Table 57: Manx Personal Accident and Health Insurance - Total Assets (GBP Billion), 2008-2012
Table 58: Manx Personal Accident and Health Insurance - Total Assets (GBP Billion), 2012-2017
Table 59: Manx Personal Accident and Health Insurance - Retentions (GBP Billion), 2008-2012
Table 60: Manx Personal Accident and Health Insurance - Retentions (GBP Billion), 2012-2017
Table 61: Manx Insurance Industry Registered Entities 2008-2012
Table 62: Tower Insurance, Main Products
Table 63: Tower Insurance, Key Employees
Table 64: Isle of Man Assurance Group (IOMA), Main Products
Table 65: Isle of Man Assurance Group (IOMA), Key Employees
Table 66: Zurich International Life Ltd, Main Products
Table 67: Zurich International Life Ltd, Key Employees

List of Figures


Figure 1: Manx Insurance Industry – Overall Written Premium by Segment (GBP Billion),
Figure 2: Manx Insurance Industry – Dynamics by Segment, 2008–2017
Figure 3: Manx Life Insurance – Gross Written Premium (GBP Billion), 2008–2012
Figure 4: Manx Life Insurance – Paid Claims (GBP Billion), 2012–2017
Figure 5: Manx Life Insurance – Paid Claims (GBP Billion), 2008–2012
Figure 6: Manx Life Insurance – Paid Claims (GBP Billion), 2012–2017
Figure 7: Manx Life Insurance – Incurred Loss (GBP Billion), 2008–2012
Figure 8: Manx Life Insurance – Incurred Loss (GBP Billion), 2012–2017
Figure 9: Manx Life Insurance – Loss Ratio (%), 2008–2012
Figure 10: Manx Life Insurance – Loss Ratio (%), 2012–2017
Figure 11: Manx Life Insurance – Combined Ratio (%), 2008–2012
Figure 12: Manx Life Insurance – Combined Ratio (%), 2012–2017
Figure 13: Manx Life Insurance – Total Assets (GBP Billion), 2008–2012
Figure 14: Manx Life Insurance – Total Assets (GBP Billion), 2012–2017
Figure 15: Manx Life Insurance – Total Investment Income (GBP Billion), 2008–2012
Figure 16: Manx Life Insurance – Total Investment Income (GBP Billion), 2012–2017
Figure 17: Manx Life Insurance – Retentions (GBP Billion), 2008–2012
Figure 18: Manx Life Insurance – Retentions (GBP Billion), 2012–2017
Figure 19: Manx Life Insurance – Investment (GBP Billion), 2008–2012
Figure 20: Manx Non-Life Insurance Written Premium by Category (GBP Billion), 2008–2017
Figure 21: Manx Non-Life Insurance Written Premium by Category (% Share), 2012 and 2017
Figure 22: Manx Non-Life Insurance Industry Dynamics by Category, 2008–2017
Figure 23: Manx Non-Life Insurance – Paid Claims (GBP Billion), 2008–2012
Figure 24: Manx Non-Life Insurance – Paid Claims (GBP Billion), 2012–2017
Figure 25: Manx Non-Life Insurance – Incurred Loss (GBP Billion), 2008–2012
Figure 26: Manx Non-Life Insurance – Incurred Loss by Category (GBP Billion), 2012–2017
Figure 27: Manx Non-Life Insurance – Loss Ratio (%), 2008–2012
Figure 28: Manx Non-Life Insurance – Loss Ratio (%), 2012–2017
Figure 29: Manx Non-Life Insurance – Combined Ratio (%), 2008–2012
Figure 30: Manx Non-Life Insurance – Combined Ratio (%), 2012–2017
Figure 31: Manx Non-Life Insurance – Total Assets (GBP Billion), 2008–2012
Figure 32: Manx Non-Life Insurance – Total Assets (GBP Billion), 2012–2017
Figure 33: Manx Non-Life Insurance – Retentions (GBP Billion), 2008–2012
Figure 34: Manx Non-Life Insurance – Retentions (US$ Billion), 2012–2017
Figure 35: Manx Property Insurance – Written Premium (GBP Billion), 2008–2012
Figure 36: Manx Property Insurance – Written Premium (GBP Billion), 2012–2017
Figure 37: Manx Motor Insurance – Written Premium (GBP Billion), 2008–2012
Figure 38: Manx Motor Insurance – Written Premium (GBP Billion), 2012–2017
Figure 39: Manx Liability Insurance – Written Premium (GBP Billion), 2008–2012
Figure 40: Manx Liability Insurance – Written Premium (GBP Billion), 2012–2017
Figure 41: Manx Marine, Aviation and Transit Insurance – Written Premium (GBP Billion), 2008–2012
Figure 42: Manx Marine, Aviation and Transit Insurance – Written Premium (GBP Billion), 2012–2017
Figure 43: Manx Personal Accident and Health Insurance – Written Premium (GBP Billion), 2008–2012
Figure 44: Manx Personal Accident and Health Insurance – Written Premium (GBP Billion), 2012–2017
Figure 45: Manx Personal Accident and Health Insurance – Paid Claims by Category (GBP Billion), 2008–2012
Figure 46: Manx Personal Accident and Health Insurance – Paid Claims (GBP Billion), 2012–2017
Figure 47: Manx Personal Accident and Health Insurance – Incurred Loss (GBP Billion), 2008–2012
Figure 48: Manx Personal Accident and Health Insurance – Incurred Loss by Category (GBP Billion), 2012–2017
Figure 49: Manx Personal Accident and Health Insurance – Loss Ratio (%), 2008–2012
Figure 50: Manx Personal Accident and Health Insurance – Loss Ratio (%), 2012–2017
Figure 51: Manx Personal Accident and Health Insurance – Combined Ratio (%), 2008–2012
Figure 52: Manx Personal Accident and Health Insurance – Combined Ratio (%), 2012–2017
Figure 53: Manx Personal Accident and Health Insurance – Total Assets (GBP Billion), 2008–2012
Figure 54: Manx Personal Accident and Health Insurance – Total Assets (GBP Billion), 2012–2017
Figure 55: Manx Personal Accident and Health Insurance – Retentions (GBP Billion), 2008–2012
Figure 56: Manx Personal Accident and Health Insurance – Retentions (US$ Billion), 2012–2017
Figure 57: Manx GDP at Current Prices (US$ Billion), 2007–2011
Figure 58: Manx GDP Per Capita (US$ ’000), 2007–2011
Figure 59: Manx Inflation Rate (%), 2007–2011
Figure 60: Manx Employed Population, 2007–2011
Figure 61: Manx Healthcare Expenditure Per Capita (US$), 2007–2011
Figure 62: Manx Healthcare Expenditure as percentage of GDP 2007–2011
Figure 63: Total Number of Air Passenger (in ‘000), 2007–2011
Figure 64: Manx Total Population (in Million), 2007–2011

Upcoming Reports:

Poland: superphosphates market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the superphosphates market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the superphosphates market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview...
Poland: cellulose market
By - Williams and Marshal Strategy
, the report presents a general overview of the economy of Poland in 2008-2012 and a forecast for its development in the medium term. The report on the cellulose market in Poland includes: Analysis and dynamics of the economy of Poland; Forecast for the development of the economy of Poland; Analysis and forecast of market volume and dynamics; Volume, dynamics and analysis of domestic production; Characteristics of market structure (by origin, by types of products, etc.); Analysis of price level and dynamics; Volume, dynamics and analysis of imports; Volume, dynamics and analysis...
Enterprise Video Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
The rapid globalization has increased the need for effective communication systems. Companies have been experiencing an escalating need of video interfaces for communication purposes, owing to its ability to increase outreach and productivity. Thus, enterprise video services are used on a large extent in these areas. The market is segmented on the basis of hardware, such as video recording and storage devices, video casting devices, video management and control and video distribution. On the basis of software the market is classified as, video content management, video analytics...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...